ArticleJournal of experimental & clinical cancer research : CR2026

HES1 inhibition overcomes CDK4/6 inhibitor resistance by targeting cancer stemness in lung adenocarcinoma.

Alvin Ho Kwan Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.